| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Immunobiology Research Group, Institute of Immunology and Virology, University of Zurich, Birchstrasse 95, CH-8050 Zurich, Switzerland
The capacities of lymphokines and of various microbes to induce in a pure population of bone marrow-derived mononuclear phagocytes tumoricidal activity and/or the production of L-arginine-dependent reactive nitrogen intermediates, measured by the release of nitrite, were comparatively assessed. These parameters were found to be closely correlated in a variety of experimental situations, i.e., enhanced by a surplus of L-arginine and abrogated by N-monomethyl-L-arginine, a selective inhibitor of L-arginine-dependent effector mechanisms. In other macrophage/tumor cell combinations, such correlation was less obvious or not at all detectable, suggesting that, in these models, L-arginine-dependent reactive nitrogen intermediates are not or not alone responsible for the mediation of tumoricidal activity by activated macrophages. Collectively, the present findings suggest that the mechanism of tumor cell killing by activated macrophages may differ, depending on the tumor cell type and the pathway of macrophage activation. Among the various effector mechanisms considered to be involved in tumor cell killing by activated macrophages, L-arginine-dependent reactive nitrogen intermediates appear to hold a major role.
1 This study was supported by the Swiss National Science Foundation (Grant 3.336.86) and the Kanton Zurich. Part of this work was done in fulfillment of the requirements for the M.D. degree for M. G. at the Faculty of Medicine, University of Zurich, Zurich, Switzerland.
2 To whom requests for reprints should be addressed.
Received 5/25/89. Revised 11/13/89. Accepted 11/27/89.
This article has been cited by other articles:
![]() |
M. Nishikawa, B. Chang, and M. Inoue Inducible NO synthase inhibits the growth of free tumor cells, but enhances the growth of solid tumors Carcinogenesis, November 1, 2004; 25(11): 2101 - 2105. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ranjan, P. Shrivastava, S. M. Singh, A. Sodhi, and N. H. Heintz Baculovirus P35 inhibits NO-induced apoptosis in activated macrophages by inhibiting cytochrome c release J. Cell Sci., June 15, 2004; 117(14): 3031 - 3039. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-E. Hu, S. O. M. Dyke, A. M. Moore, L. L. Thomsen, and K. M. Brindle Tumor Cell-Derived Nitric Oxide Is Involved in the Immune-Rejection of an Immunogenic Murine Lymphoma Cancer Res., January 1, 2004; 64(1): 152 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sodhi and S. K. Biswas fMLP-induced in vitro nitric oxide production and its regulation in murine peritoneal macrophages J. Leukoc. Biol., February 1, 2002; 71(2): 262 - 270. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Klimp, H. Hollema, C. Kempinga, A. G. J. van der Zee, E. G. E. de Vries, and T. Daemen Expression of Cyclooxygenase-2 and Inducible Nitric Oxide Synthase in Human Ovarian Tumors and Tumor-associated Macrophages Cancer Res., October 1, 2001; 61(19): 7305 - 7309. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Naama, V. E. Mack, G. P. Smyth, P. P. Stapleton, and J. M. Daly Macrophage Effector Mechanisms in Melanoma in an Experimental Study Arch Surg, July 1, 2001; 136(7): 804 - 809. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Goto, K. Haruma, Y. Kitadai, M. Ito, M. Yoshihara, K. Sumii, N. Hayakawa, and G. Kajiyama Enhanced Expression of Inducible Nitric Oxide Synthase and Nitrotyrosine in Gastric Mucosa of Gastric Cancer Patients Clin. Cancer Res., June 1, 1999; 5(6): 1411 - 1415. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |